These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15725480)

  • 41. The activity of zoledronic Acid on neuroblastoma bone metastasis involves inhibition of osteoclasts and tumor cell survival and proliferation.
    Peng H; Sohara Y; Moats RA; Nelson MD; Groshen SG; Ye W; Reynolds CP; DeClerck YA
    Cancer Res; 2007 Oct; 67(19):9346-55. PubMed ID: 17909043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental study of 131I-labeled granulocyte macrophage colony-stimulating factor in SCID mouse-acute myeloid leukemia model].
    Deng YJ; Lou SF; Xu YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):33-6. PubMed ID: 17649724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
    Tauchi T; Shin-ya K; Sashida G; Sumi M; Okabe S; Ohyashiki JH; Ohyashiki K
    Oncogene; 2006 Sep; 25(42):5719-25. PubMed ID: 16652154
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological activity of isoprenoid bisphosphonates.
    Shull LW; Wiemer AJ; Hohl RJ; Wiemer DF
    Bioorg Med Chem; 2006 Jun; 14(12):4130-6. PubMed ID: 16517172
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of a daunorubicin analogue that exhibits potent antitumor activity and overcomes P-gp-mediated drug resistance.
    Fang L; Zhang G; Li C; Zheng X; Zhu L; Xiao JJ; Szakacs G; Nadas J; Chan KK; Wang PG; Sun D
    J Med Chem; 2006 Feb; 49(3):932-41. PubMed ID: 16451059
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-delta.
    Kurosu T; Tsuji K; Kida A; Koyama T; Yamamoto M; Miura O
    Oncogene; 2007 May; 26(21):2975-87. PubMed ID: 17130834
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Coriolus versicolor (Yunzhi) extract attenuates growth of human leukemia xenografts and induces apoptosis through the mitochondrial pathway.
    Ho CY; Kim CF; Leung KN; Fung KP; Tse TF; Chan H; Lau CB
    Oncol Rep; 2006 Sep; 16(3):609-16. PubMed ID: 16865263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
    Wu W; Rochford R; Toomey L; Harrington W; Feuer G
    Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antileukemic effect of a synthetic vitamin D3 analog, HY-11, with low potential to cause hypercalcemia.
    Yoon JS; Kim JY; Park HK; Kim ES; Ahn KS; Yoon SS; Cho CG; Kim BK; Lee YY
    Int J Oncol; 2008 Feb; 32(2):387-96. PubMed ID: 18202761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Induction of caspase-3-dependent apoptosis in human leukemia HL-60 cells by paclitaxel.
    Lu KH; Lue KH; Liao HH; Lin KL; Chung JG
    Clin Chim Acta; 2005 Jul; 357(1):65-73. PubMed ID: 15963795
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo.
    Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA
    Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anticancer effects of zoledronic acid against human osteosarcoma cells.
    Kubista B; Trieb K; Sevelda F; Toma C; Arrich F; Heffeter P; Elbling L; Sutterlüty H; Scotlandi K; Kotz R; Micksche M; Berger W
    J Orthop Res; 2006 Jun; 24(6):1145-52. PubMed ID: 16602111
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia.
    Fiegl M; Juergens M; Hiddemann W; Braess J
    Leuk Res; 2007 Apr; 31(4):531-9. PubMed ID: 16939689
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synergistic growth inhibition of YM529 with biologic response modifiers (BRMs) in myeloma cells.
    Yata K; Otsuki T; Yamada O; Wada H; Yawata Y; Sugihara T
    Int J Hematol; 2002 Jun; 75(5):534-9. PubMed ID: 12095156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel third generation bisphosphonate, minodronate (YM529), prevented proliferation and migration of hepatocellular carcinoma cells through inhibition of mevalonate pathway.
    Kogure T; Ueno Y; Kimura O; Kondo Y; Inoue J; Fukushima K; Iwasaki T; Shimosegawa T
    Hepatol Res; 2009 May; 39(5):479-89. PubMed ID: 19207585
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proposed mechanism for induction of heat shock protein 70 by geranylgeranyl acetone by prenylation of Ras proteins.
    Bar-Or D
    Crit Care Med; 2003 Nov; 31(11):2700-1. PubMed ID: 14605546
    [No Abstract]   [Full Text] [Related]  

  • 58. [Antimitotic chemotherapy and proliferative activity of leukemic cells].
    Astaldi G; Meardi G
    Minerva Med; 1966 Mar; 57(25):1094-6. PubMed ID: 5932009
    [No Abstract]   [Full Text] [Related]  

  • 59. [Effect of cytostatics on leukemic cells in vivo].
    Tigges FJ; Wilms K
    Verh Dtsch Ges Inn Med; 1978; (84):171-3. PubMed ID: 742041
    [No Abstract]   [Full Text] [Related]  

  • 60. [Chemotherapy and proliferative potentiality of the leukemic elements].
    Dogliotti GC; Pileri A
    Minerva Med; 1966 Mar; 57(25):1086-90. PubMed ID: 5932007
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.